Monpellerin consistently explores and adopts innovative technologies, integrating the concept of combining science and medicine into clinical practice. While intensifying research efforts, it continuously strengthen the commercialization of scientific findings. Supports in application technology by 133 universities including the University of Pennsylvania, Warsaw Medical University, the University of Tokyo, the University of Pittsburgh, the University of Florida, Massey University, the University of London, the University of Hong Kong, and National Taiwan University provide technological backing for the company's rapid and sustainable growth.